FOAM-study, Cost Minimization Study Comparing Surgery Versus Duplex Guided Foam Sclerotherapy of Varicose Veins

This study has been completed.
Sponsor:
Collaborator:
ZonMw: The Netherlands Organisation for Health Research and Development
Information provided by:
Maastricht University Medical Center
ClinicalTrials.gov Identifier:
NCT01103258
First received: April 6, 2010
Last updated: April 12, 2010
Last verified: April 2010

April 6, 2010
April 12, 2010
February 2006
December 2009   (final data collection date for primary outcome measure)
cumulative probability of recurrent varicose vein within 24 months after treatment [ Time Frame: 24 months ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT01103258 on ClinicalTrials.gov Archive Site
  • quality of life (as measured by EuroQol-5D) [ Time Frame: 24 months ] [ Designated as safety issue: No ]
  • patient preferences (as measured by conjoint analysis) [ Time Frame: 24 months ] [ Designated as safety issue: No ]
  • direct Health care costs [ Time Frame: 24 months ] [ Designated as safety issue: No ]
    materials, operation costs, personnel costs
Same as current
Not Provided
Not Provided
 
FOAM-study, Cost Minimization Study Comparing Surgery Versus Duplex Guided Foam Sclerotherapy of Varicose Veins
FOAM-study Cost Minimization Study Comparing Surgery Versus Duplex Guided Foam Sclerotherapy of Varicose Veins: a Randomized Controlled Study

Varicose vein disease is a common health problem, which causes much discomfort to patients.

Nowadays treatment modalities for greater saphenous veins include surgery and duplex guided foam sclerotherapy. These are two equally accepted and applied treatments for the same patient population.

Choice of treatment often depends on the referral preference of the General Practitioner. Until now data are missing which treatment is more cost effective. The current proposal aims at comparing the effects, costs and patient preferences between duplex guided foam sclerotherapy and surgery in the treatment of greater varicose veins.

Not Provided
Interventional
Not Provided
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Varicose Vein Disease
  • Procedure: high ligation and stripping (surgery)
    surgery consisting of high ligation in combination with long saphenous stripping
  • Procedure: FOAM
    duplex guided foam sclerotherapy
  • Active Comparator: high ligation and stripping
    surgery consisting of high ligation in combination with long saphenous stripping
    Intervention: Procedure: high ligation and stripping (surgery)
  • Active Comparator: duplex guided foam sclerotherapy
    duplex guided foam sclerotherapy
    Intervention: Procedure: FOAM
Shadid N, Ceulen R, Nelemans P, Dirksen C, Veraart J, Schurink GW, van Neer P, vd Kley J, de Haan E, Sommer A. Randomized clinical trial of ultrasound-guided foam sclerotherapy versus surgery for the incompetent great saphenous vein. Br J Surg. 2012 Aug;99(8):1062-70. doi: 10.1002/bjs.8781. Epub 2012 May 25.

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
460
January 2010
December 2009   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • incompetence of great saphenous vein for minimal 20 cm
  • life expectancy at least 3 years
  • open and competent deep venous system
  • willing to undergo both treatments

Exclusion Criteria:

  • active ulcer
  • signs of deep venous thrombosis with duplex
  • incompetence of the deep venous system
Both
18 Years and older
No
Contact information is only displayed when the study is recruiting subjects
Netherlands
 
NCT01103258
MEC 05-2-014, ZON MW 4636
No
Dr A Sommer, Maastricht UMC
Maastricht University Medical Center
ZonMw: The Netherlands Organisation for Health Research and Development
Study Director: A Sommer, MD PhD Maastricht UMC
Maastricht University Medical Center
April 2010

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP